CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-31 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +4,400 | 4,400 | ||
| 2021-05-11 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +3,750 | 3,750 | ||
| 2020-05-12 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2019-05-14 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +7,000 | 7,000 | ||
| 2018-09-20 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2017-08-01 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +16,400 | 16,400 | ||
| 2017-08-01 | Joseph Donald Director | Grant or award · Stock Option (right to buy) | +16,400 | 16,400 |
Page 1 of 1 · 7 trades